| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/26/2012 | US20120022236 Recombinant Anti-VLA4 Antibody Molecules |
| 01/26/2012 | US20120022136 Cellular Genes Regulated by HIV-1 Infection and Methods of Use Thereof |
| 01/26/2012 | US20120022133 Antisense modulation of cholesteryl ester transfer protein expression |
| 01/26/2012 | US20120022034 Methods for reducing or neovascularization or edema |
| 01/26/2012 | US20120022006 B-lymphocyte stimulator binding polypeptides and methods based thereon |
| 01/26/2012 | US20120022005 Synthetic Dragline Spider Silk-Like Proteins |
| 01/26/2012 | US20120022004 Treatment of t-cell mediated diseases |
| 01/26/2012 | US20120022003 Method of using diketopiperazines and composition containing them |
| 01/26/2012 | US20120022002 SUSTAINED RELEASE siRNA FOR OCULAR DRUG DELIVERY |
| 01/26/2012 | US20120022001 Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle |
| 01/26/2012 | US20120022000 Use of a peptide in the treatment or prevention of metastasis |
| 01/26/2012 | US20120021999 Pro-apoptotic peptides |
| 01/26/2012 | US20120021998 Cancer Diagnosis and Treatment Methods of Use |
| 01/26/2012 | US20120021997 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| 01/26/2012 | US20120021996 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| 01/26/2012 | US20120021995 Polypeptides that Bind TRAIL-R1 and TRAIL-R2 |
| 01/26/2012 | US20120021994 Novel cancer antigen eef2 |
| 01/26/2012 | US20120021993 Protein scaffold library based on kringle domain structure and uses thereof |
| 01/26/2012 | US20120021992 Methods for improving neurological outcome after neural injury and neurodegenerative disease |
| 01/26/2012 | US20120021991 Use of a botulinum neurotoxin to alleviate various disorders |
| 01/26/2012 | US20120021990 Peptides useful as dual caspase-2/-6 inhibitors and their biological applications |
| 01/26/2012 | US20120021989 Genetic markers for risk management of atrial fibrillation and stroke |
| 01/26/2012 | US20120021988 Methods for treating immune thrombocytopenia |
| 01/26/2012 | US20120021987 Mucin 3 EGF-Like Domains |
| 01/26/2012 | US20120021986 Protecting and repairing cartilage and musculoskeletal soft tissues |
| 01/26/2012 | US20120021985 Albumin fusion proteins |
| 01/26/2012 | US20120021984 Glycoprotein Hormone Analogs |
| 01/26/2012 | US20120021983 Compositions and methods for diagnosis and prognosis of cancer and progression, and for screening anti-cancer agents |
| 01/26/2012 | US20120021982 Pharmaceutical compositions for the treatment of left ventricular diastolic dysfunction |
| 01/26/2012 | US20120021981 Compositions to prevent and treat type-1 diabetes |
| 01/26/2012 | US20120021980 Compositions for drug administration |
| 01/26/2012 | US20120021979 GLP-1 receptor modulation of addiction, neuropsychiatric disorders and erectile dysfunction |
| 01/26/2012 | US20120021978 Combination of an insulin and a glp-1-agonist |
| 01/26/2012 | US20120021977 Promotion of healthy catch-up growth |
| 01/26/2012 | US20120021976 Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders |
| 01/26/2012 | US20120021975 Antibiotic peptides |
| 01/26/2012 | US20120021974 Novel inhibitor of angiogenesis |
| 01/26/2012 | US20120021973 Peptides for Treatment of Obesity |
| 01/26/2012 | US20120021972 Peptidomimetics with glucagon antagonistic and glp 1 agonistic activities |
| 01/26/2012 | US20120021971 Functional Food Product Comprising Heat Shock Protein or a Hydrolysate Thereof |
| 01/26/2012 | US20120021970 Methods for preventing or treating mitochondrial permeability transition |
| 01/26/2012 | US20120021969 Prosthetic implant shell |
| 01/26/2012 | US20120021968 Methods for treating or preventing urological inflammation |
| 01/26/2012 | US20120021967 Synthetic antibodies |
| 01/26/2012 | US20120021518 Growth factor homolog zvegf4 |
| 01/26/2012 | US20120021425 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 01/26/2012 | US20120021078 nutritional composition comprising an apple extract and reducing food allergy symptoms, especially in children |
| 01/26/2012 | US20120021073 Systemic administration of nac as an adjunct in the treatment of bioterror exposures such as smallpox and use in combination with dhea for the treatment of smallpox |
| 01/26/2012 | US20120021072 Compositions For The Treatment And Prevention Of Eyelid Swelling |
| 01/26/2012 | US20120021071 Use of a synergistic combination of hypothiocyanite and/or hypohalite ions and lactoferrin for preparing a treatment for cystic fibrosis |
| 01/26/2012 | US20120021063 Crosslinked material comprising elastin and collagen, and use thereof |
| 01/26/2012 | US20120021058 Process for making dry and stable hemostatic compositions |
| 01/26/2012 | US20120021054 Tablet formulation of ezatiostat |
| 01/26/2012 | US20120021047 Id-1 Gene and Gene Products as Therapeutic Targets for Treatment of Breast Cancer and Other Types of Carcinoma |
| 01/26/2012 | US20120021045 Methods for Inhibiting Cancer Cell Proliferation |
| 01/26/2012 | US20120021043 Nucleic Acids Comprising formula (NuGlXmGnNv)a and Derivatives Thereof as Immunostimulating Agent/Adjuvant |
| 01/26/2012 | US20120021042 Efficient Method For Loading Amphoteric Liposomes With Nucleic Acid Active Substances |
| 01/26/2012 | US20120021040 Therapeutic agent for spinal cord injuries |
| 01/26/2012 | US20120021039 Expression of neuropeptides in mammalian cells |
| 01/26/2012 | US20120021038 Coating composition |
| 01/26/2012 | US20120021036 Composite nanostructures and methods for making and using them |
| 01/26/2012 | US20120021033 DISPERSIN B POLYNUCLEOTIDES AND METHODS OF PRODUCING RECOMBINANT DspB POLYPEPTIDES |
| 01/26/2012 | US20120021029 Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions |
| 01/26/2012 | US20120021020 Branched amphipathic oligo-peptides that self-assemble into vesicles |
| 01/26/2012 | US20120021018 Microspheres for the sustained release of octreotide with a low initial burst |
| 01/26/2012 | US20120021006 Egfr-homing double-stranded rna vector for systemic cancer treatment |
| 01/26/2012 | US20120020991 Prodomain modulators of adam 10 |
| 01/26/2012 | US20120020979 METHODS FOR TREATING IgE-MEDIATED DISORDER |
| 01/26/2012 | US20120020977 Pancreatic cancer genes |
| 01/26/2012 | US20120020975 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 01/26/2012 | US20120020974 Optimizing erythropoietin therapy |
| 01/26/2012 | US20120020970 Methods of evaluating patients |
| 01/26/2012 | US20120020960 Thymic Stromal Lymphopoietin (TSLP) and OX40 Ligand in Cancer |
| 01/26/2012 | US20120020959 Use of the sparc microenvironment signature in the treatment of cancer |
| 01/26/2012 | US20120020955 Detection of Neurological Disorders With Immune Reactions |
| 01/26/2012 | US20120020953 Diagnosis and treatment of cancer |
| 01/26/2012 | US20120020951 Adverse side-effects associated with administration of anti-hyaluronan agents and methods for ameliorating or preventing the side-effects |
| 01/26/2012 | US20120020950 Antibacterial compounds |
| 01/26/2012 | US20120020948 Dag-type and indirect protein kinase c activators and anticoagulant for the treatment of stroke |
| 01/26/2012 | US20120020947 Compositions and methods for increasing lean muscle mass after exercise |
| 01/26/2012 | US20120020940 Antimicrobial peptides |
| 01/26/2012 | US20120020932 Thermosensitive hydrogel composition and method |
| 01/26/2012 | US20120020923 Method of treating viral diseases with combinations of TPO receptor agonist and anti-viral agents |
| 01/26/2012 | US20120020922 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 01/26/2012 | US20120020921 1'-substituted-carba-nucleoside prodrugs for antiviral treatment |
| 01/26/2012 | US20120020920 5-5-membered fused heterocyclic compound and use thereof as hcv polymerase inhibitor |
| 01/26/2012 | US20120020919 Methods for treating viral infection using il-28 and il-29 |
| 01/26/2012 | US20120020918 Il-1 family variants |
| 01/26/2012 | US20120020917 Methods for accelerating wound healing by administration of adipokines |
| 01/26/2012 | US20120020916 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
| 01/26/2012 | US20120020915 Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System |
| 01/26/2012 | US20120020914 Leukemia inhibitory factor (lif) for use in repressing human papillomavirus (hpv) transcription |
| 01/26/2012 | US20120020913 Methods for pancreatic tissue regeneration |
| 01/26/2012 | US20120020912 Prostate cancer vaccine |
| 01/26/2012 | US20120020911 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
| 01/26/2012 | US20120020890 Staphylococcus aureus proteins and nucleic acids |
| 01/26/2012 | US20120020889 Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 and Alpha V Beta 3 Integrin |
| 01/26/2012 | US20120020888 Biomarker |
| 01/26/2012 | US20120020882 Peptide-based compounds |
| 01/26/2012 | US20120020881 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes |